Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Join the club for FREE to access the whole archive and other member benefits.
Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Micro-robots clear sinus infections in animals by targeting bacteria with heat and light
New device delivers results in minutes, helping doctors treat patients faster and more accurately
Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Nafithromycin offers a fast, powerful treatment against resistant infections
Click on resource name for more details.
No blog posts found!